Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Dubermatinib

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Sumitomo Dainippon Oncology Announces First Patient Dosed in the Dubermatinib
    Sumitomo Dainippon Oncology Announces First Patient Dosed in the Dubermatinib

    23 Oct 2020

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/sumitomo-dainippon-pharma-oncology-announces-first-patient-dosed-in-the-dubermatinib-arm-of-the-leukemia--lymphoma-societys-beat-aml-master-clinical-trial-in-patients-with-acute-myeloid-leukemia-301158414.html

    PRNEWSWIRE
    23 Oct 2020
    Share Share
    SumitomoDainipponPharma Oncology Presents PhI Study Evaluating Dubermatinib:ESMO
    SumitomoDainipponPharma Oncology Presents PhI Study Evaluating Dubermatinib:ESMO

    18 Sep 2020

    // BIOSPACE

    https://www.biospace.com/article/releases/sumitomo-dainippon-pharma-oncology-presents-findings-from-phase-1-clinical-study-evaluating-investigational-agent-dubermatinib-in-patients-with-advanced-solid-tumors-at-esmo-2020-virtual-annual-congress/

    BIOSPACE
    18 Sep 2020
    Share Share